Domperidone for Acid Reflux & LPR: Does It Work?

If you have been researching prokinetics, you have probably run into domperidone. It comes up a lot in reflux forums, usually framed as the drug that “tightens the valve” and “speeds up your stomach.” The short answer is that domperidone can help some people with acid reflux and LPR, but it works best as an add-on to acid suppression rather than a standalone fix, the evidence for silent reflux specifically is thin and mixed, and it carries a genuine cardiac safety consideration that changed how regulators allow it to be used.

Domperidone is a prokinetic and anti-sickness medicine that increases lower oesophageal sphincter pressure and helps the stomach empty faster. In theory that means fewer reflux events reaching your throat. In practice, it is a prescription-only medicine in the UK, and it is not approved for human use at all in the United States, so this is very much a “talk to your doctor” drug rather than something to self-source.

I have managed my own LPR for over eight years, so I want to walk through what domperidone actually does mechanistically, what the studies show for GERD versus silent reflux, and the safety trade-offs that too many articles skip over.

Key Takeaways

• Domperidone is a prokinetic: it blocks dopamine (D2) receptors in the gut, which raises lower oesophageal sphincter tone and speeds up gastric emptying.
• It is an adjunct, not a cure. The strongest evidence is for adding domperidone to a proton pump inhibitor (PPI) in GERD, where the combination beats a PPI alone for symptom relief.
• Evidence for LPR/silent reflux is limited and mixed. Some trials favour adding a prokinetic; at least one found domperidone plus omeprazole was no better than omeprazole on its own.
• Cardiac safety is the catch. Domperidone is linked to a small increased risk of QT prolongation and serious heart-rhythm problems, which is why regulators restricted it.
• Doses are kept low and short. Typical use is 10 mg up to three times daily, capped at 30 mg per day, for the shortest sensible duration.
• Availability differs by country. Prescription-only in the UK and EU; not FDA-approved for human use in the US.
• It does not replace the fundamentals. Diet, meal timing, and pepsin management still do the heavy lifting in LPR.

What Is Domperidone?

Domperidone (sold under brand names such as Motilium) is a dopamine-receptor antagonist. It was originally developed as an anti-emetic — a drug that reduces nausea and vomiting — but it also has useful prokinetic effects, meaning it encourages the muscles of the upper gut to move contents along more efficiently.

What sets it apart from an older cousin like metoclopramide is that domperidone barely crosses the blood-brain barrier. That means far fewer neurological side effects, which historically made it an appealing option for longer-term gut motility problems. As you will see, though, “appealing” ran into some hard safety data.

How Domperidone Works for Reflux and LPR

This is where I always start, because if you understand the mechanism, the rest of the article makes sense. Domperidone influences reflux through three linked actions.

1. It raises lower oesophageal sphincter pressure

The lower oesophageal sphincter (LES) is the ring of muscle that is meant to stay shut and only open when you swallow. When it is weak or relaxes at the wrong moment, stomach contents escape upward. By blocking dopamine receptors in the gut, domperidone increases the tone of that muscle, making it a more competent barrier. If you want the deeper picture of how this valve behaves in silent reflux, I cover it in my guide to the stomach sphincter and LPR.

2. It speeds up gastric emptying

A stomach that empties slowly stays fuller for longer, and a fuller stomach means more pressure pushing contents back toward that sphincter. Domperidone enhances the coordinated contractions that move food out of the stomach and into the small intestine, which reduces the reservoir of material available to reflux in the first place.

3. It improves oesophageal clearance

Better peristalsis also helps sweep any refluxed material back down more quickly, so it spends less time irritating the tissue above.

Domperidone is described in the research as a dopaminergic blocker that increases lower oesophageal sphincter pressure and activates gastric motility [Zamani et al., Journal of Clinical Medicine, 2022].

Here is the LPR-specific angle that generic GERD articles miss. In silent reflux, the damage is driven less by acid alone and more by pepsin — a stomach enzyme that hitches a ride upward and can be reactivated by acid in the throat. Domperidone does nothing to neutralise pepsin directly. What it can do is reduce the number of reflux events that carry pepsin up to your larynx in the first place. That is a meaningful supporting role, but it is why I never think of it as the main event. If pepsin is your problem, you also need a strategy to neutralise pepsin in the throat.

Does Domperidone Help GERD? What the Evidence Says

For classic acid reflux (GERD), the evidence for domperidone as an add-on is actually reasonably encouraging. A systematic review and meta-analysis pooling 11 randomised trials and 841 participants found that combining a PPI with domperidone produced a significant reduction in overall GERD symptoms compared with a PPI alone, with side effects no worse than the PPI by itself [Zamani et al., Journal of Clinical Medicine, 2022].

The key word there is combination. Domperidone tackles the mechanical side of reflux (the barrier and emptying), while the PPI tackles the acid. They address different parts of the same problem, which is why they can complement each other. This is most relevant if your symptoms include a “dyspepsia” flavour — bloating, fullness, and slow digestion alongside the reflux. If your reflux medication is not fully controlling things, it is worth reading why acid reflux medication sometimes does not work before adding another drug.

Does Domperidone Help LPR and Silent Reflux?

This is the question I get asked most, and I have to be honest: the LPR evidence is thinner and less consistent than the GERD evidence.

A systematic review of prokinetics for laryngopharyngeal reflux found only four eligible prospective studies, all judged to be at high risk of bias. Three of the four showed a symptom benefit favouring prokinetics, but the authors concluded the overall body of literature was inadequate to formally recommend them for LPR [Glicksman et al., The Laryngoscope, 2014].

Domperidone specifically has been put to the test. In a randomised trial of 70 LPR patients, adding domperidone (10 mg three times daily) to omeprazole was no better than omeprazole alone — both groups improved by roughly 70% on the Reflux Symptom Index, with no significant difference between them [Hunchaisri, Journal of the Medical Association of Thailand, 2012].

A more recent systematic review of controlled LPR treatments echoed that prokinetics and alginates are plausible options that increase sphincter pressure and improve clearance, but stressed that we still need proper randomised trials before drawing firm conclusions [Lechien et al., Journal of Otolaryngology – Head and Neck Surgery, 2025].

My take, after years of living with this: domperidone is a reasonable adjunct to try under medical supervision if standard treatment plus lifestyle change is not enough — particularly when slow gastric emptying seems to be part of your picture. It is not a reliable stand-alone answer for silent reflux, and it should never be the first thing you reach for. If you are new to the condition, my silent reflux treatment guide and the difference between GERD vs LPR are better starting points.

Domperidone Dosage for Reflux

Dosing is always your prescriber’s call, but the standard adult pattern you will see is 10 mg taken up to three times a day, ideally 15–30 minutes before meals so it is active while your stomach is working. Because it is a prokinetic, timing it before food makes mechanistic sense.

Two rules matter here, and they come straight from the safety restrictions:

• Do not exceed 30 mg per day. Higher daily doses are where the cardiac risk climbs.
• Use it for the shortest effective duration. Domperidone is meant for short courses, not indefinite daily use.

This short-course philosophy is one reason I lean so heavily on diet and habit change: those are the things you can safely sustain for the long haul, whereas a drug like this is a limited-window tool.

The Cardiac Safety Question You Cannot Skip

This is the part of the domperidone story that gets glossed over in enthusiastic forum posts, and it is the reason regulators reined the drug in.

A European Medicines Agency review confirmed a small increased risk of serious cardiac side effects with domperidone, including QT-interval prolongation, torsade de pointes, serious ventricular arrhythmia, and sudden cardiac death. The risk was higher in people over 60, at daily doses above 30 mg, and in those taking other QT-prolonging medicines or drugs that slow domperidone’s breakdown [European Medicines Agency, 2014].

A later systematic review and meta-analysis of observational studies examined domperidone and the risk of sudden cardiac death and ventricular arrhythmia, reinforcing why those age and dose thresholds exist [Ou et al., British Journal of Clinical Pharmacology, 2021].

To put this in perspective: the absolute risk for a healthy younger adult on a low, short-term dose is small. But “small” is not “zero,” and it is exactly why domperidone should be prescribed after a doctor has checked your heart history, your other medications, and your risk factors — not bought online and taken on a hunch. If you have a known heart-rhythm condition or take other QT-affecting drugs, this drug is generally off the table.

Is Domperidone Available in the UK and US?

Availability is genuinely different depending on where you live, and this trips people up constantly.

In the UK, domperidone was moved to prescription-only status and its licensed use narrowed to nausea and vomiting, after the safety review. It is no longer officially licensed for heartburn and is used for reflux/motility purposes off-label, under a prescriber’s judgement.

In the United States, domperidone is not approved for any human use. The FDA states plainly that it is not a legally marketed drug there and has been linked to serious cardiac events including arrhythmias, cardiac arrest, and sudden death; limited access exists only through a tightly controlled expanded-access programme for specific severe gastrointestinal cases [U.S. Food and Drug Administration]. Importing it personally is not a safe or legal shortcut, and product quality from unofficial sources cannot be trusted.

Where Domperidone Fits in a Real LPR Plan

Here is how I frame it for anyone weighing it up. Domperidone is a mechanical helper: it can make your valve a bit tighter and your stomach empty a bit faster, which lowers the number of reflux events. That is useful. What it does not do is heal an irritated larynx, clear pepsin, or fix the dietary and lifestyle triggers driving the reflux in the first place.

So if a doctor prescribes it, I would treat it as a temporary boost layered on top of the fundamentals, not a substitute for them. Those fundamentals — the right foods, the right meal timing, managing pepsin, and giving inflamed tissue a chance to settle — are what create durable improvement. If you also take a PPI, do not stop it abruptly to swap in domperidone; read about getting off PPIs and acid rebound first, because rebound can undo your progress.

The dietary side is where I have seen the biggest, most lasting changes, and it is exactly what my Wipeout Diet Plan is built around — reducing reflux frequency and giving your throat the low-irritation environment it needs to recover.

Conclusion

Domperidone is a legitimate tool for reflux, but it is a supporting act rather than the star. Mechanistically it makes good sense — tightening the lower oesophageal sphincter and speeding up gastric emptying are exactly the levers you want to pull to reduce reflux events. For classic GERD, the evidence backs it up as a useful add-on to acid suppression. For LPR and silent reflux specifically, the data is thinner and more mixed, and at least one solid trial found it added nothing over a PPI alone.

The cardiac safety signal is the reason I always urge caution and proper medical oversight. This is a prescription-only medicine in the UK, unavailable for general use in the US, and it belongs in the hands of a doctor who can check your heart history and your other medications first. Low dose, short duration, and never off an unofficial online source.

Most importantly, do not let any single drug distract you from the foundations. In my experience, the people who get genuinely better are the ones who fix what is on their plate and how they eat, not the ones chasing the perfect pill. If you want a clear, practical starting point, my Wipeout Diet Plan is the in-depth, step-by-step system I wish I had at the beginning, and the Wipeout Food Reference Guide is the essential companion that lays out exactly which foods and drinks are reflux-friendly and their pH values, so you can make safe choices from day one. Get those working first, and let any medication be the boost on top — not the whole plan.

Frequently Asked Questions

Does domperidone stop acid reflux?

Not on its own. Domperidone reduces reflux events by tightening the lower oesophageal sphincter and speeding up gastric emptying, but it does not suppress acid. For GERD it works best combined with a PPI, where the pairing outperforms a PPI alone for symptom relief.

Is domperidone good for LPR or silent reflux?

It may help some people as an adjunct, especially if slow gastric emptying is part of the picture, but the evidence is limited and mixed. One randomised trial found domperidone plus omeprazole was no better than omeprazole alone for LPR, so it is not a reliable stand-alone treatment.

What is the correct domperidone dose for reflux?

The typical adult dose is 10 mg up to three times daily, taken before meals, and capped at 30 mg per day. It is meant for short courses. Your prescriber sets the exact dose based on your health and other medications.

Is domperidone safe for the heart?

It carries a small increased risk of QT prolongation and serious heart-rhythm problems, which is why regulators restricted it. Risk is higher over age 60, above 30 mg per day, and alongside other QT-prolonging drugs. Anyone with a heart-rhythm condition should generally avoid it.

Why is domperidone not available in the US?

The FDA has not approved domperidone for any human use because of its cardiac safety concerns. It is only accessible through a tightly controlled expanded-access programme for specific severe gastrointestinal disorders, and personal importation is neither safe nor legal.

Can I take domperidone with a PPI like omeprazole?

This combination is common and is where domperidone has the strongest GERD evidence, but it should be done under medical supervision. Your doctor will check for drug interactions, since some medicines that slow domperidone’s breakdown raise the cardiac risk.

How long does domperidone take to work?

It is absorbed quickly and reaches peak levels roughly half an hour after an oral dose, so its prokinetic effect kicks in fairly soon after taking it. Symptom improvement over a course of treatment is more gradual and varies from person to person.

Research Sources

• [Zamani et al., Journal of Clinical Medicine, 2022] — A meta-analysis of 11 randomised trials (841 patients) found that adding domperidone to a PPI significantly reduced global GERD symptoms versus a PPI alone, with comparable side effects.
• [Glicksman et al., The Laryngoscope, 2014] — A systematic review of prokinetics for LPR identified only four eligible studies with mixed results and high bias, concluding the evidence was inadequate to formally recommend prokinetics for LPR.
• [Hunchaisri, Journal of the Medical Association of Thailand, 2012] — A randomised trial of 70 LPR patients found domperidone plus omeprazole was not superior to omeprazole alone; both groups improved by around 70% on the Reflux Symptom Index.
• [Lechien et al., Journal of Otolaryngology – Head and Neck Surgery, 2025] — A systematic review of controlled LPR treatments noted prokinetics and alginates as plausible options but called for randomised trials before firm recommendations.
• [Ou et al., British Journal of Clinical Pharmacology, 2021] — A systematic review and meta-analysis of observational studies assessed domperidone’s association with sudden cardiac death and ventricular arrhythmia, supporting the dose and age-based safety cautions.
• [European Medicines Agency, 2014] — Confirmed a small increased risk of serious cardiac events (QTc prolongation, torsade de pointes, ventricular arrhythmia, sudden cardiac death) and restricted domperidone to the lowest effective dose for the shortest duration.
• [U.S. Food and Drug Administration] — States that domperidone is not FDA-approved for any human use and has been associated with serious cardiac adverse events including arrhythmias, cardiac arrest, and sudden death.